In response to a significant ongoing disruption to the supply of Monomil® XL 60mg tablets, a Serious Shortage Protocol (SSP) has been issued by the Department of Health and Social Care (DHSC). Effective today 26th March 2024, SSP059 provides that for every Monomil® XL 60mg tablets originally prescribed one alternative brand of a Isosorbide mononitrate 60mg modified-release tablets
Read moreThe Drug Tariff Preface published monthly lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 April 2024. Part VIIIA – Basic prices of drugs Contractors should note changes made to: Basic Price of Drugs covered by Part II Clause 8A
Read moreFrom 1 April 2024, the pack size listings of Xarelto® (Rivaroxaban) 1mg/ml granules for oral suspension will be updated. This follows the identification by Community Pharmacy England of a discrepancy in the pack size listings for Xarelto® (Rivaroxaban) 1mg/ml granules for oral suspension. Currently, the pack sizes listed in the Drug Tariff and the NHS
Read moreCommunity Pharmacy England is looking for a Dispensing and Supply Pharmacist to join our Pharmacy Funding Team. If you’re passionate about community pharmacy and eager to support pharmacy owners through this specialised role, we’re keen to hear from you. The Dispensing and Supply Pharmacist will be responsible for providing professional expertise on policy areas concerning
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Insulatard® InnoLet® (insulin isophane human) 100units/ml suspension for injection 3ml pre-filled disposable devices MSN/2024/032 Tier 2 – medium impact Date of issue: 21st March 2024 Insulatard® InnoLet® (insulin isophane human) 100units/ml suspension for injection 3ml pre-filled disposable devices are being discontinued
Read moreClass 4 Medicines Defect Information: Sodium Chloride Intravenous Infusion 0.9% Freeflex (Fresenius Kabi Limited) Drug alert number: EL (24)A/10 Date issued: 21 March 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Sodium Chloride Intravenous Infusion 0.9% Freeflex (Fresenius Kabi Limited) Company name: Fresenius Kabi
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Levemir InnoLet® (insulin detemir) 100units/ml solution for injection 3ml pre-filled disposable devices. MSN/2024/033 Tier 2 – medium impact Date of issue: 21st March 2024 Levemir® InnoLet® (insulin detemir) 100units/ml solution for injection 3ml pre-filled disposable devices are being discontinued with remaining
Read moreThe NHS Business Services Authority (NHSBSA) has emailed pharmacy owners today to say that the Pharmacy First IT system suppliers have resolved issues with the data they supplied to the Manage Your Service (MYS) portal for the February 2024 NHS Pharmacy First activity. NHS England and the Department of Health and Social Care have also
Read moreFollowing discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (20/03/2024) announced the following list of price concessions for March 2024: Drug Pack size Price concession Anastrozole 1mg tablets 28 £1.45 Azithromycin 250mg capsules 6 £4.45 Baclofen 10mg
Read moreCommunity Pharmacy England’s third annual Pressures Survey is underway, and many pharmacy owners and teams have been responding. Thank you to everyone who has already responded to the survey during this busy time; we very much appreciate your support. However, we’re keen to hear from even more voices across the sector. Every contribution is important
Read more
